The Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018 (2018 No 54) is an
Act of Parliament
Acts of Parliament, sometimes referred to as primary legislation, are texts of law passed by the Legislature, legislative body of a jurisdiction (often a parliament or council). In most countries with a parliamentary system of government, acts of ...
in
New Zealand
New Zealand ( mi, Aotearoa ) is an island country in the southwestern Pacific Ocean. It consists of two main landmasses—the North Island () and the South Island ()—and over 700 smaller islands. It is the sixth-largest island count ...
which amends the
Misuse of Drugs Act 1975
The Misuse of Drugs Act 1975 is a New Zealand drug control law that classifies drugs into three classes, or schedules, purportedly based on their projected risk of serious harm. However, in reality, classification of drugs outside of passing law ...
to allow terminally-ill people to consume
cannabis
''Cannabis'' () is a genus of flowering plants in the family Cannabaceae. The number of species within the genus is disputed. Three species may be recognized: ''Cannabis sativa'', '' C. indica'', and '' C. ruderalis''. Alternatively ...
and to possess a
cannabis
''Cannabis'' () is a genus of flowering plants in the family Cannabaceae. The number of species within the genus is disputed. Three species may be recognized: ''Cannabis sativa'', '' C. indica'', and '' C. ruderalis''. Alternatively ...
utensil. The bill passed its third reading on 11 December 2018.
It was supported by the centre-left
Labour Party and its coalition partners
New Zealand First
New Zealand First ( mi, Aotearoa Tuatahi), commonly abbreviated to NZ First, is a nationalist and populist political party in New Zealand. The party formed in July 1993 following the resignation on 19 March 1993 of its leader and founder, Winst ...
and the
Green parties
A green party is a formally organized political party based on the principles of green politics, such as social justice, environmentalism and nonviolence.
Greens believe that these issues are inherently related to one another as a foundation f ...
but was opposed by the opposition centre-right
National Party.
The Act received royal assent on 17 December and came into force on 18 December 2018.
Legislative features
The Misuse of Drugs (Medicinal Cannabis) Amendment Act amends the
Misuse of Drugs Act 1975
The Misuse of Drugs Act 1975 is a New Zealand drug control law that classifies drugs into three classes, or schedules, purportedly based on their projected risk of serious harm. However, in reality, classification of drugs outside of passing law ...
to:
*introduce an exception and a statutory defence for those requiring
palliative care
Palliative care (derived from the Latin root , or 'to cloak') is an interdisciplinary medical caregiving approach aimed at optimizing quality of life and mitigating suffering among people with serious, complex, and often terminal illnesses. Wit ...
to possess and use illicit
cannabis
''Cannabis'' () is a genus of flowering plants in the family Cannabaceae. The number of species within the genus is disputed. Three species may be recognized: ''Cannabis sativa'', '' C. indica'', and '' C. ruderalis''. Alternatively ...
and to possess a cannabis utensil;
*provide a regulation-making power to enable the setting of standards that products manufactured, imported, and supplied under licence must meet; and
*amend Schedule 2 of the Act so that
cannabidiol
Cannabidiol (CBD) is a phytocannabinoid discovered in 1940. It is one of 113 identified cannabinoids in cannabis plants, along with tetrahydrocannabinol (THC), and accounts for up to 40% of the plant's extract. , clinical research on CBD incl ...
(CBD) and CBD products are no longer classed as controlled drugs.
This Act intends to improve access to both
medicinal cannabis
Medical cannabis, or medical marijuana (MMJ), is cannabis and cannabinoids that are prescribed by physicians for their patients. The use of cannabis as medicine has not been rigorously tested due to production and governmental restrictions ...
and medicinal cannabis products of a quality standard. Cannabis compounds that are still classified as controlled drugs are
tetrahydrocannabinol
Tetrahydrocannabinol (THC) is the principal psychoactive constituent of cannabis and one of at least 113 total cannabinoids identified on the plant. Although the chemical formula for THC (C21H30O2) describes multiple isomers, the term ''THC'' ...
s and related
psychoactive substances
A psychoactive drug, psychopharmaceutical, psychoactive agent or psychotropic drug is a chemical substance, that changes functions of the nervous system, and results in alterations in perception, mood, consciousness, cognition or behavior.
T ...
.
Both the populist
New Zealand First
New Zealand First ( mi, Aotearoa Tuatahi), commonly abbreviated to NZ First, is a nationalist and populist political party in New Zealand. The party formed in July 1993 following the resignation on 19 March 1993 of its leader and founder, Winst ...
and the left-wing
Green Party
A green party is a formally organized political party based on the principles of green politics, such as social justice, environmentalism and nonviolence.
Greens believe that these issues are inherently related to one another as a foundation ...
secured concessions to the Amendment Act including the inclusion of anyone in palliative care rather than those defined as terminally ill and the establishment of a regulated local market that allows native strains of cannabis rather than imported cannabis products. The
Minister of Health A health minister is the member of a country's government typically responsible for protecting and promoting public health and providing welfare and other social security services.
Some governments have separate ministers for mental health.
Coun ...
David Clark has also confirmed that medicinal cannabis products will be available on prescription.
However, no individual may leave or enter New Zealand with illicit cannabis even if they have been diagnosed by a medical or nurse practitioner as requiring palliation. Individuals can still travel with one month's supply of medicines that are controlled drugs such as
Sativex
Nabiximols (USAN, trade name Sativex) is a specific ''Cannabis'' extract that was approved in 2010 as a botanical drug in the United Kingdom. Nabiximols is sold as a mouth spray intended to alleviate neuropathic pain, spasticity, overactive bla ...
or three months' supply of medicines that are not controlled drugs (CBD products) provided they are able to show that the drugs have been lawfully supplied to them.
History
Introduction
The Misuse of Drugs (Medicinal Cannabis) Amendment Bill was first introduced on 30 January 2018 by Health Minister David Clark. It passed its first reading and was referred to the parliamentary Health Committee. At that stage, the Bill was supported by both the
Labour-led coalition government and the opposition centre-right
National Party. This Bill is not to be confused with Green MP
Chlöe Swarbrick
Chlöe Charlotte Swarbrick (born 26 June 1994) is a New Zealand politician. Following a high-profile but unsuccessful run for the 2016 Auckland mayoral election, she became a parliamentary candidate for the Green Party of Aotearoa New Zealand ...
's similarly named Misuse of Drugs (Medical Cannabis and Other Matters) Amendment Bill, which did not pass its first reading on 31 January.
Health Committee report
On 24 July 2018, the National Party withdrew its support for the Government's Bill and proposed its own an alternative bill which it claimed would set out a more comprehensive and well-researched regime regulating medicinal cannabis. National MP
Shane Reti
Shane Raymond Reti (born 5 June 1963) is a New Zealand politician and a member of the New Zealand House of Representatives, first elected at the 2014 general election. He is a member of the New Zealand National Party and served as its deputy ...
's bill proposed allowing medicinal cannabis products with the exception of loose leaf cannabis to be regulated the same way as medicine, classifying medicinal cannabis as pharmacist–only medicine, and giving doctors the right to issue identification cards that would allow patients to purchase medicinal cannabis. Health Minister Clark opposed the bill, claiming National was playing politics.
On 25 July, the parliamentary Health Committee released its report to Parliament. Since the Committee was unable to reach an agreement on the Bill, it was unable to recommend the passage of the bill. The Health Committee received 1,786 written submissions on the bill with the vast majority expressing support for legalising medicinal cannabis. Only 1% opposed the intents of the bill. The Health Committee also heard 158 oral submissions, which were largely supportive of the bill. Submitters' concerns included expanding access to those with other medical conditions, the regulation of medicinal cannabis products, lack of a clear definition of terminal illnesses, and calls for a full risk assessment of cannabidioil.
The Ministry of Health also recommended several amendments included providing a legal defence for the terminally ill to possess cannabis; setting regulations to prescribe standards for all stages of cultivation, production, and manufacture of cannabis; to allow the Director-General of Health to communicate information about the availability of medicinal cannabis products; maintaining a prohibition on tetrahydrocannabinols capable of inducing a psychoactive effect on individuals, and allowing CBD products to contain some non-psychoactive cannabinoids that are naturally found in cannabis. The Labour Party expressed support for the bill as a means of decriminalizing medicinal cannabis. While the National Party supported making medicinal cannabis more easily accessible, it expressed concerns about the wording of the bill and the manufacture, distribution, and eligibility of medicinal cannabis products.
The cannabis law reform organization
NORML New Zealand
NORML New Zealand is a cannabis law reform organisation in New Zealand. It is a National Chapter of the National Organization for the Reform of Marijuana Laws (NORML).
Media and activism
NORML New Zealand publish the print and electronic quarte ...
issued a submission voicing support for descheduling CBD products but allowing a wider 5% tolerance for other cannaboids to improve production and affordability; broadening the defence to include patients with terminal illnesses, chronic or debilitating medical conditions where the doctor has prescribed the use of cannabis; allowing the cultivation of cannabis; and taking a herbal remedy approach towards non-pharmaceutical cannabis products. While supportive of the Government's proposed
Medicinal Cannabis Access Scheme
Medicine is the science and practice of caring for a patient, managing the diagnosis, prognosis, prevention, treatment, palliation of their injury or disease, and promoting their health. Medicine encompasses a variety of health care pract ...
, it advocated a "patient-focused regime" that allowed local cultivation as opposed to what it termed a "corporate pharmaceutical-style scheme."
Second Reading
Following the Health Committee's report, the Bill passed its second reading on 29 November 2018. The Bill was supported by the ruling coalition parties and National, which had reversed its previous opposition on the condition that some of its own legislation including those pertaining to banning of smoking "loose-leaf" cannabis be incorporated into the final bill. During its second reading, the revised Bill incorporated several changes including extending the use of medicinal cannabis to all needing palliative care; require that regulations for a Medicinal Cannabis Scheme be set up within a year after the law comes into effect; permit the use of cannabis varieties already available in New Zealand to be used for medicinal products; and revising THC thresholds for CBD medicinal products.
The Bill was subsequently referred to the Committee of the whole House on 5 December 2018.
Third reading
On 11 December, the Misuse of Drugs (Medicinal Cannabis) Bill passed its third reading. The bill was supported by Labour, New Zealand First and the Greens (63) but opposed by National (53). NZ First health spokesperson
Jenny Marcroft
Jennifer Lyn Marcroft (born 1963) is a New Zealand politician and Member of Parliament in the House of Representatives for the New Zealand First party.
She served from 2017 to 2020, and returned in the 2023 New Zealand general election.
Early ...
praised the inclusion of anyone in palliative care under the bill as a compassionate approach that would provide 25,000 people with a defence for using medicinal cannabis. Greens drug reform spokesperson Chloe Swarbrick said the bill would allow the development of a domestic market for regulated cannabis products. Health Minister and bill initiator David Clark stated that the bill would allow medicinal cannabis to be made available on prescription.
By contrast, National claim that the bill amounted to the decriminalisation of cannabis by stealth, "We support medicinal cannabis but strongly oppose the smoking of loose leaf cannabis in public. Smoked loose leaf is not a medicine" said spokesman Shane Reti.
Royal Assent
On 17 December, the
act received royal assent and commenced the following day.
Referendum on recreational consumption of cannabis
Also on 18 December, the Government announced that a nationwide, binding referendum on recreational consumption of cannabis would be held as part of the
2020 general election.
References
External links
*
*
*
{{Cannabis in New Zealand
2018 in New Zealand law
Cannabis in New Zealand
Drug control law
Drug policy of New Zealand
Statutes of New Zealand